Novartis says Kisqali boosts survival in breast cancer patients
Novartis said on Sunday
that Kisqali helped women with advanced breast cancer after
menopause live longer, adding to data the Swiss company hopes
will help convince doctors to choose its drug over Pfizer’s
blockbuster Ibrance.
that Kisqali helped women with advanced breast cancer after
menopause live longer, adding to data the Swiss company hopes
will help convince doctors to choose its drug over Pfizer’s
blockbuster Ibrance.
Posted by Reuters
